文献速递主动脉疾病

开窗与分支支架腔内治疗慢性主动脉夹层

Endovascular treatment of chronic aortic dissection with fenestrated and branched stent grafts.
PubMed 文献 · J Vasc Surg · 2020-10-15

单中心回顾性研究纳入2010-2019年26例慢性主动脉夹层患者,行开窗/分支支架腔内修复(F/B-EVAR),短期技术成功率89%,30天死亡率4%,中期内漏发生率44%,TAAA组再干预率较高。

要点

  • F/B-EVAR治疗慢性夹层动脉瘤可行,短期和中期结果可接受。
  • 开窗弓部修复后逆行A型夹层需警惕,尤其原发升主动脉未处理者。
  • TAAA修复后再干预频繁,3年免于再干预率仅48%。

核心结论

  • F/B-EVAR治疗夹层后动脉瘤可行,短期和中期结果可接受,但弓部修复后逆行A型夹层需谨慎,TAAA修复后再干预频繁。

研究设计与样本

  • 单中心回顾性研究,纳入2010-2019年Uppsala大学医院接受F/B-EVAR的26例慢性主动脉夹层患者,中位年龄63岁,中位随访23个月。

主要发现

  • 短期技术成功24/27例(89%),30天死亡率4%(1例),截瘫3例(11%),卒中3例(11%)。
  • 中期内漏12例(44%),3年生存率弓部组75%、TAAA组93%,3年免于再干预率弓部组100%、TAAA组48%。
  • 随访超过6个月的23例患者主动脉直径均稳定或减小,支架段完全假腔血栓形成占65%(15例)。

临床怎么用

  • 弓部开窗修复应警惕逆行A型夹层,尤其慢性B型夹层且升主动脉未处理者。
  • TAAA修复后需密切随访,再干预率较高。

局限性

  • 单中心回顾性研究,样本量小(26例),随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chronic aortic dissection with aneurysm development that includes the aortic arch and/or thoracoabdominal aorta (TAAA) is traditionally treated with open or hybrid surgery. Total endovascular treatment with fenestrated and branched aortic repair (F/B-EVAR) has recently been introduced as a less invasive alternative. The aim was to report the short- and midterm outcomes from a single tertiary vascular center. METHODS: All patients with chronic aortic dissection treated with F/B-EVAR from 2010 to 2019 at Uppsala University Hospital were identified. Perioperative and postoperative parameters were analyzed, with focus on short- (<30 days) and midterm survival, complication, and reintervention rates. RESULTS: F/B-EVAR was performed on 26 patients (median age, 63 years; range, 33-87 years; 18 men; median aortic diameter, 70 mm; range, 50-98 mm); with a median follow-up of 23 months (range, 0.5-118.0 months). One patient underwent both arch and TAAA repair. Overall, 13 arch repairs (arch group) after type A (n = 8) and type B (n = 5) dissection (all elective) were performed, and 14 TAAA repairs (TAAA group) after type A (n = 5) and type B (n = 9) dissection (one rupture). A total of 72 aortic branches were targeted (22 arch, 50 TAAA). Short-term technical success was achieved in 24 of 27 procedures (89%). Failures were related to one intraoperative retrograde type A dissection (RTAD) requiring open conversion (arch group), one persistent type IC endoleak on completion angiography (arch group), and one persistent type III endoleak (TAAA group). Mortality was 4% (n = 1) at 30 days and related to a second RTAD that occurred after discharge and was found on autopsy. Both RTADs occurred in patients with chronic type B dissection undergoing fenestrated arch repair. Paraplegia occurred in three cases (two arch, one TAAA) (11%), none permanent, and stroke in three cases (one arch, one TAAA) (11%); one was permanent. In the midterm, endoleaks were detected in 12 patients (44%); persistent false lumen flow (n = 3), type IB (n = 1), type IC (n = 3), type II (n = 7), and type IIIC (n = 2). The 3-year survival (Kaplan-Meier) of the arch repair was 75% and for the TAAA, 93%. Freedom from reintervention at 3 years were 100% for arch repairs and 48% for TAAA. In patients with a follow-up of more than 6 months (n = 23), all had stable or decreased aortic diameters and complete false lumen thrombosis at the level of stent graft was present in 65% (n = 15). CONCLUSIONS: Endovascular treatment of postdissection aneurysms is feasible, with acceptable short-term and midterm outcomes. RTAD after fenestrated and branched endovascular arch repair warrants caution when performed on patients with native ascending aortas, and reinterventions are frequent in TAAA repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kuzniar MK, Wanhainen A, Tegler G, et al. Endovascular treatment of chronic aortic dissection with fenestrated and branched stent grafts. J Vasc Surg. 2020. PMID: 33068767. doi:10.1016/j.jvs.2020.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。